Pfizer (NYSE:PFE) licensed Novavax’s Matrix-M adjuvant technology to support future vaccine development. The company received FDA Breakthrough Therapy Designation for a combination of Sutent and ...
The vaccine maker’s shots involve the successful Covid vaccines’ RNA technology. Health Secretary Robert F. Kennedy Jr. has ...
WASHINGTON — U.S. regulators approved updated COVID-19 shots Wednesday but limited their use for many Americans — and removed one of the two vaccines available for young children. The new shots from ...
PFE, has entered a global licensing agreement with Novavax to use Matrix-M adjuvant technology in the development of up to two infectious disease vaccines. The deal grants Pfizer non-exclusive ...
A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...
Scientists say they have identified a mutated autoantibody gene as the mechanism behind rare but serious abnormal blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results